Silence Therapeutics plc (SLN) stock
SLNNasdaqPharmaceutical PreparationsAlso trades as SLNCF
$19.83+0.03 (+0.15%)
Close on Nov 13, 2026Market cap $936.90MP/E –Yield –
Silence Therapeutics statistics
79 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Mar 4, 2027 (estimated, before the open)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Jun 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 33.29
- 2.22
Enterprise valuationIndustry
- EV / Sales
- 1406.18
- 2.57
Share statisticsIndustry
- Shares Change (YoY)
- 0.10%
- 10.8%
- Shares Change (QoQ)
- 0.02%
- 0.50%
- Float
- 74M
- 49M
- Shares Held by Insiders
- 48.1%
- 11.7%
- Shares Held by Institutions
- 16.6%
- 56.4%
Short sellingIndustry
- Short Interest
- 2M
- –
- Short Interest Change
- -17.4%
- -0.80%
- Days to Cover
- 1.00
- 5.15
Stock price statisticsIndustry
- 52-Week High
- $19.86
- –
- 52-Week Low
- $4.19
- –
- 20-Day Moving Average
- $19.74
- –
- 50-Day Moving Average
- $14.66
- –
- 200-Day Moving Average
- $9.78
- –
- Average True Range (14)
- $0.40
- –
- Price Change (1 Week)
- 0.51%
- -1.15%
- Price Change (1 Month)
- 112.1%
- -4.87%
- Price Change (3 Months)
- 38.2%
- -21.0%
- Price Change (6 Months)
- 225.1%
- -20.6%
- Price Change (YTD)
- 226.2%
- -23.6%
- Price Change (1 Year)
- 194.7%
- -22.4%
- Price Change (3 Years)
- 115.1%
- -29.5%
- Price Change (5 Years)
- -12.6%
- -77.9%
- Average Volume (10 Days)
- 866,095
- –
- Average Volume (20 Days)
- 6M
- –
- Average Volume (90 Days)
- 2M
- –
- Relative Volume
- 0.27
- 0.70
- Relative Strength Index (14)
- 78.3
- 43.4
- Volatility (1 Year)
- 149.6%
- 80.1%
- Beta (5 Years)
- 1.05
- 1.07
MarginsIndustry
- Pretax Margin
- -9748.1%
- -11.6%
- EBITDA Margin
- -11106.8%
- -27.7%
- FCF Margin
- -6872.5%
- -9.56%
Returns on capitalIndustry
- Return on Equity (ROE)
- -90.4%
- -49.9%
- Return on Assets (ROA)
- -44.1%
- -40.6%
- Return on Capital Employed (ROCE)
- -72.9%
- -37.9%
Financial positionIndustry
- Current Ratio
- 7.42
- 3.30
- Quick Ratio
- 5.67
- 2.39
GrowthIndustry
- Revenue Growth (YoY)
- -97.7%
- 6.82%
- Revenue Growth (3Y CAGR)
- -70.4%
- 2.25%
EfficiencyIndustry
- Asset Turnover
- 0.00
- 0.40
- Revenue Per Employee
- $6.99K
- $429.29K
- Profits Per Employee
- -$681.28K
- -$689.41K
- Employee Count
- 88
- 74
- WACC
- 10.4%
- 10.2%
Income statement (TTM)Industry
- Pretax Income
- -$59.95M
- -$12.95M
Balance sheetIndustry
- Net Cash (Debt)
- $72.10M
- $17.76M
- Net Cash Per Share
- $0.51
- $0.80
- Equity (Book Value)
- $38.47M
- $53.89M
- Book Value Per Share
- $0.27
- $1.50
- Tangible Book Value
- $28.15M
- $27.13M
- Working Capital
- $81.57M
- $79.99M
Cash flow (TTM)Industry
- Capital Expenditures
- -$3.00K
- -$1.00M
- FCF Per Share
- -$0.30
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- -6.40%
- -21.8%
- FCF Yield
- -4.51%
- -9.44%
- Buyback Yield
- -0.00%
- -0.76%
- Shareholder Yield
- -0.00%
- 0.00%
Taxes and interestIndustry
- Income Tax
- $2.00K
- $73.00K
Scores and fair valueIndustry
- Altman Z-Score
- -0.68
- 0.23
- Piotroski F-Score
- 2
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | SLN | S&P 500 | Difference | SLN per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +123.6% | -3.0% | +126.6 pts | ||
| 3 months | +41.9% | -2.8% | +44.7 pts | ||
| Year to date | +226.2% | +11.5% | +214.7 pts | ||
| 1 year | +186.6% | +13.5% | +173.1 pts | ||
| 3 years | +120.1% | +77.7% | +42.4 pts | +30.1% | +21.1% |
| 5 years | -12.6% | +72.6% | −85.3 pts | -2.7% | +11.5% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
2M SLN shares were sold short on Oct 30, 2026, down 17.4% from the previous report. At recent volumes it would take 1.0 days to buy them back. Over the last 20 sessions, 21.0% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 2,418,248 | -17.4% | 9,216,885 | 1.0 |
| Oct 15, 2026 | 2,927,366 | +15.3% | 1,270,099 | 2.3 |
| Sep 30, 2026 | 2,538,328 | +16.5% | 827,101 | 3.1 |
| Sep 15, 2026 | 2,178,055 | -10.6% | 861,199 | 2.5 |
| Aug 31, 2026 | 2,435,831 | +0.1% | 695,204 | 3.5 |
| Aug 14, 2026 | 2,432,830 | +32.4% | 2,891,078 | 1.0 |
| Jul 31, 2026 | 1,837,238 | +16.8% | 560,270 | 3.3 |
| Jul 15, 2026 | 1,572,687 | -9.3% | 499,806 | 3.1 |
| Jun 30, 2026 | 1,733,018 | -16.1% | 772,826 | 2.2 |
| Jun 15, 2026 | 2,066,488 | +0.4% | 241,168 | 8.6 |
| May 29, 2026 | 2,057,236 | +3.6% | 225,140 | 9.1 |
| May 15, 2026 | 1,985,927 | -7.9% | 181,913 | 10.9 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?